Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
‘House keys’ protests by Meerut women changed Oyo’s policy on unwed couples
Oyo will now require proof of marriage from couples for lodging at its properties in Meerut, in response to protests about ‘illegal activities’ involving unwed […]
Pakistan flags painted on roads spark tension in Goa
Tension escalated in Canacona as Pakistani flags were discovered painted on roads at key locations early Friday, raising concerns about potential communal disharmony. Goa assembly […]
‘Cut, cut, cut’: Rahul takes a jibe at PM over meeting with Kapoor family
Congress leader Rahul Gandhi criticized PM Modi’s meeting with the Kapoor family, urging him to focus on “real issues”. Gandhi contrasted his interactions with workers […]